MedDRA helps evaluators describe the health effects of tobacco products in consistent terms. Read More
While some fear government regulation, others welcome the regulatory clarity. Read More
The measure is part of the government’s commitment to become smoke-free by 2025.Read More
The substance could be considered a ‘component,' says CTP Director Zeller.Read More
The company’s application has been placed back into the PMTA review process.Read More
In its haste to process millions of PMTAs, the FDA took a shortcut, documents suggest. Read More
The company is still seeking a judicial stay pending the outcome of its lawsuit. Read More
Altria discontinued its Verven oral tobacco product three years ago. Read More
This marks the first set of ENDS products ever to be authorized through the PMTA pathway. Read More
The company’s marketing application was not properly assessed, says FDA.Read More
Recent Posts
- Quebec Lobby Groups Blind to Illicit Trade: Imperial
- Sales Down, Profit up at Turning Point Brands
- Vector Group Reports First-Quarter Results
- U.S. DEA Asks White House to Reclassify Marijuana
- The Great Scramble
- A Perfect Storm
- Real-World Quitting
- Japan Tobacco to Keep Russian Business
- Support for Filter Ban at Plastics-Pollution Summit
- The Path Less Traveled
- Smart and Smooth
- Feeling the Squeeze
- Driving Transformation
- Doubling Down on Failure
- Dan Gallagher President Smoker Friendly